Clinical Trial Update: The Switching Antiplatelet-9 (SWAP-9) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for SWAP-9, a study evaluating switching antiplatelet therapy in patients with coronary artery disease. The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Florida | Conditions: Coronary Arterial Disease (CAD) | Phase 4 | Status: RECRUITING